(Q37868436)

24 August 2017

0 references

Multiple myeloma emerging after prolonged gefitinib treatment for non-small cell lung carcinoma (English)

1 reference

24 August 2017

1 reference

1 reference

Sian Yik Lim

1

1 reference

24 August 2017

Sachiko Ando

series ordinal

2

1 reference

24 August 2017

Kaoru Nishiyama

series ordinal

3

1 reference

24 August 2017

Simi Padival

series ordinal

4

1 reference

24 August 2017

6 April 2011

1 reference

24 August 2017

Case reports in oncology

1 reference

24 August 2017

4

1 reference

24 August 2017

1

1 reference

24 August 2017

198-203

1 reference

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

24 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Three cases of synchronous solid tumor and multiple myeloma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Definitive diagnosis of multiple myeloma from rib specimens resected at thoracotomy in a patient with lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Subsequent malignant neoplasms in cancer survivors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Myeloma aetiology and epidemiology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Pesticides and lung cancer risk in the agricultural health study cohort

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080785

Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer

1 September 2018

1 reference

12 December 2020

Synchronous presentation of multiple myeloma and lung cancer

1 reference

12 December 2020

Activity of cetuximab as single agent in a patient with relapsed multiple myeloma.

1 reference

12 December 2020

Patients with multiple myeloma and solid tumors: six case reports

1 reference

12 December 2020

Epidemiology of Lung Cancer*

1 reference

12 December 2020

Identifiers

DOI

10.1159/000327689

1 reference

24 August 2017

1 reference

24 August 2017

PubMed publication ID

21516269

1 reference